Entering text into the input field will update the search result below

Biodesix inks stock purchase deal for up to $50M with Lincoln Park Capital

Mar. 07, 2022 4:05 PM ETBDSXBy: Jessica Kuruthukulangara, SA News Editor
  • Biodesix (NASDAQ:BDSX) entered into a purchase agreement for the issue and sale of its stock, from time to time, of up to $50M with institutional investor Lincoln Park Capital Fund.
  • BDSX will have the right at its sole discretion, but not

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.